COVINA, CA -- (MARKET WIRE) -- March 06, 2007 -- Healtheuniverse, Inc. (PINKSHEETS: HLUN), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, announced today that it is completing its infrastructure development in Singapore for its adult stem cell research and development center. The wholly owned subsidiary, Healtheuniverse Ptd Ltd., will collaborate with other research and development facilities in Asia in preparation for clinical trials. Expansion of pre-clinical and clinical capabilities in Singapore is a cornerstone in the Company’s development of the first commercial stem cell therapy in the $15 billion worldwide plastic, reconstructive and cosmetic surgery market.
